12月5日创业板医疗（970082）指数涨1.16%，成份股福瑞股份（300049）领涨

Core Viewpoint - The ChiNext Medical Index (970082) closed at 3662.68 points on December 5, with a 1.16% increase and a trading volume of 7.133 billion yuan, indicating positive market sentiment in the medical sector [1]. Group 1: Index Performance - On the day, 46 out of the index's constituent stocks rose, with Furuide (福瑞股份) leading the gains at 7.09%, while 4 stocks declined, with Ruimaite (瑞迈特) experiencing the largest drop at 0.59% [1]. - The index's turnover rate was 1.0%, reflecting moderate trading activity [1]. Group 2: Top Constituents - The top ten constituents of the ChiNext Medical Index include: - Yuaner Eye Hospital (爰尔眼科) with a weight of 8.87% and a latest price of 11.30 yuan [1]. - Mindray Medical (迈瑞医疗) with a weight of 8.02% and a latest price of 202.39 yuan [1]. - Kanglong Chemical (康龙化成) with a weight of 7.41% and a latest price of 29.21 yuan [1]. - Other notable constituents include Taige Medical (泰格医药), Lepu Medical (乐普医疗), and Aimeike (爱美客) [1]. Group 3: Capital Flow - On the same day, the net outflow of main funds from the index's constituents totaled 256 million yuan, while retail investors saw a net inflow of 279 million yuan [1]. - The detailed capital flow for specific stocks shows that Furuide had a main fund net inflow of 27.11 million yuan, despite a net outflow from retail and speculative funds [2]. Group 4: Index Adjustments - Recent adjustments to the ChiNext Medical Index included the addition of two stocks: Chaoyan Co. (超研股份) and Hualan Co. (华兰股份), while Lanwei Medical (兰卫医学) and Meikang Bio (美康生物) were removed [3].